GLYCOMACROPEPTIDE FORMULA WITH LONG CHAIN POLYUNSATURATED FATTY ACIDS AND DOCOSAHEXAENOIC ACID AND LOW IN PHENYLALANINE

Information current as at: 1 June 2026

Legend: Completed N In progress Not applicable N Yet to commence

Submission Details

Brand name:
  • PKU Sphere Liquid
Form and strength:
Please search for and view the medicine's Public Summary Document (PSD) for more information
Submission sponsor:
VITAFLO AUSTRALIA PTY LIMITED
Condition/indication:
(therapeutic use)
  • Phenylketonuria
Listing requested:
Please see PSD for more information
Funding program:
Please see PSD for more information
Request authority level:
Please see PSD for more information
PBAC Submission type:
New PBS listing (–)
Comment:
--
Other PBAC consideration:
--

Progress Details

Submission received for:
November 2022 PBAC meeting
Opportunity for consumer comment:
Open 27/07/2022 and close 21/09/2022 (see PBS Website)
PBAC meeting:
Held on 02/11/2022
PBAC outcome published:
Recommended (see PBAC Outcomes)
Notice of intent submitted:
02/12/2022
Lodgement of required documentation:
13/12/2022
Acceptance of complete documentation:
Accepted
Agreement to listing arrangements:
Commenced on 16/12/2022
Status:
Finalised
Government processes:
Commenced on 24/03/2023
Medicine listed on the PBS:
01/05/2023 (see PBS schedule)

PBAC Outcome

PBAC Recommendation:
Please see the Outcomes from the relevant meeting for more information

Case ID
a589
Page last updated
31 March 2026
v.9.19